Segmed

Executive Summary

Segmed is a pioneering real-world imaging data (RWiD) company that provides a self-serve platform for accessing high-quality, de-identified, and regulatory-grade medical imaging datasets. Founded by Stanford engineers and physicians, the company aggregates data from a global network of healthcare providers to support AI development, clinical research, and regulatory submissions for life sciences and technology companies. Its mission is to accelerate healthcare innovation by streamlining secure data access for research and development. In an era where medical AI requires large, diverse, and compliant datasets, Segmed addresses a critical bottleneck by offering a scalable solution that reduces the time and cost of data acquisition. The platform's ability to provide regulatory-grade data positions it as a key enabler for AI-driven diagnostic tools and therapeutics. With a focus on high-quality, de-identified data, Segmed serves a growing market of healthcare AI companies and research institutions, making it a compelling player in the digital health ecosystem.

Upcoming Catalysts (preview)

• Q4 2026Strategic Partnership with Major Healthcare Network70% success
• Q2 2026Series B Funding Round80% success
• Q1 2027FDA Clearance for Data Curation Process65% success